Kedrion Biopharma
Sara Taglialatela, Pharm.D. has a diverse work experience in the pharmaceutical industry. Sara started their career as a Regulatory Affairs Assistant at Segix Italia Srl in 2001, followed by a role as a Regulatory Affairs Specialist at Pfizer from 2001 to 2004. From 2004 to 2008, they worked at Pierrel Spa as a Regulatory Affairs and GMP Compliance Advisor, where they managed projects, prepared regulatory dossiers, and conducted inspections.
In 2009, Sara joined Kedrion Biopharma as a GMP Compliance Manager, responsible for quality system management and ensuring compliance with regulations. Sara then became a Quality Compliance Manager from 2012 to 2018, overseeing quality and regulatory compliance at Kedrion's manufacturing plant in Naples.
Sara's next role was as a Quality Assurance Manager and Qualified Person at Kedrion Biopharma, where they led a team of 23 people and managed the GMP Quality System. Sara also handled regulatory affairs, prepared CMC files, and conducted audits and inspections.
Currently, Sara holds the position of Global Quality Operations Manager and QP at Kedrion Biopharma. Their responsibilities include designing and monitoring quality processes, supporting plants in remediation and inspection readiness activities, and managing a team of professionals. Sara is also the Qualified Person for the Kedrion plant in Naples, Italy.
Sara Taglialatela, Pharm.D. holds a Laurea in CTF (Chimica e tecnologia farmaceutica) from Università degli Studi di Napoli Federico II, which they obtained from 1995 to 2000. Prior to that, they received a Diploma di Maturità Classica from Liceo Classico, with no specific field of study mentioned. In addition, they have certifications including Qualified Person from AIFA Agenzia Italiana del farmaco, Role Model from Valore D, and The European Qualified Person Association from ECA Foundation & ECA Academy.
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.